Credit Suisse Ag Zentalis Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 48,438 shares of ZNTL stock, worth $144,829. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,438

Previous 48,917 0.98%

Holding current value

$144,829

Previous $741,000 2.97%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$10.83 - $16.49 $5,187 - $7,898	-479 Reduced 0.98%	48,438 $763,000
Q4 2023 Feb 08, 2024	SELL	$9.84 - $20.13 $13,687 - $28,000	-1,391 Reduced 2.76%	48,917 $741,000
Q3 2023 Nov 13, 2023	SELL	$19.63 - $28.29 $186,583 - $268,896	-9,505 Reduced 15.89%	50,308 $1.01 Million
Q2 2023 Aug 11, 2023	BUY	$17.41 - $30.05 $390,750 - $674,442	22,444 Added 60.06%	59,813 $1.69 Million
Q1 2023 May 10, 2023	BUY	$16.14 - $24.94 $193 - $299	12 Added 0.03%	37,369 $642,000
Q4 2022 Feb 13, 2023	SELL	$18.07 - $25.6 $6,776 - $9,600	-375 Reduced 0.99%	37,357 $752,000
Q3 2022 Nov 10, 2022	BUY	$20.23 - $31.73 $47,317 - $74,216	2,339 Added 6.61%	37,732 $818,000
Q2 2022 Aug 12, 2022	BUY	$17.91 - $52.25 $282,333 - $823,669	15,764 Added 80.31%	35,393 $995,000
Q1 2022 May 16, 2022	BUY	$41.58 - $80.89 $94,719 - $184,267	2,278 Added 13.13%	19,629 $905,000
Q4 2021 Feb 14, 2022	BUY	$66.92 - $84.79 $331,454 - $419,964	4,953 Added 39.95%	17,351 $1.46 Million
Q3 2021 Nov 12, 2021	BUY	$46.83 - $73.5 $7,633 - $11,980	163 Added 1.33%	12,398 $827,000
Q2 2021 Aug 16, 2021	SELL	$37.41 - $62.25 $27,309 - $45,442	-730 Reduced 5.63%	12,235 $652,000
Q1 2021 May 14, 2021	SELL	$35.69 - $52.72 $657,017 - $970,522	-18,409 Reduced 58.68%	12,965 $563,000
Q4 2020 Feb 12, 2021	BUY	$31.71 - $57.97 $994,869 - $1.82 Million	31,374 New	31,374 $1.63 Million

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

67.9M

Call Options Held

48.5K

Put Options Held

89.6K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $170M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account